FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...
Las Vegas Review-Journal4h
FDA proposes pulling decongestants from shelves over ingredient
Just as cold and flu season arrives, the Food and Drug Administration proposes pulling many decongestants ... For some ...
CBS News on MSN1d
FDA to pull common but ineffective cold medicine from market
The Food and Drug Administration announced Wednesday that it would seek ... concluded that the oral version of the drug is ...
U.S. FDA proposes ending use of popular decongestant present in cold medicines
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...
WSB-TV6h
FDA proposes oral phenylephrine, found in many decongestants, pulled from shelves
The Food and Drug Administration proposed that oral phenylephrine be removed ... Vicks DayQuil and Mucinex Sinus-Max, CNN ...
Health on MSN8h
FDA Plans to Ban Ineffective Cold Medicine Ingredient—How It Will Affect You
The FDA had proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold ...
FDA proposes removing ineffective decongestant found in most cold medicine
The Food and Drug Administration (FDA) is proposing to remove from the market a common ingredient found in most oral over-the ...
Yahoo1d
The FDA wants to ban a common ingredient in over-the-counter cold and allergy medications
The U.S. Food and Drug Administration (FDA) announced today that it is proposing a new rule to stop the use of an ingredient ...
Men's Journal on MSN23h
FDA Recommends Removing Ingredient From Many Cold and Allergy Medicines After Research Shows It Doesn't Work
Cold and flu season is upon us and Americans will be flocking to pharmacy shelves to pick up some medicine to alleviate their ...
STAT1d
How a Trump presidency could affect the FDA, the biotech industry, and its stocks
STAT's Readout LOUD podcast discusses how Trump's second term and the MAHA movement could affect FDA regulation, the ...
UPI News on MSN1d
FDA says commonly used decongestant 'not effective,' proposes removal
Nov. 7 (UPI) --The U.S. Food and Drug Administration has determined commonly used oral phenylephrine is "not effective" and ...
Cure Today3h
FDA Approves CAR-T Cell Therapy for Relapsed or Refractory B-Cell ALL
The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...